APASL guidance on stopping nucleos(t)ide analogues in chronic hepatitis B patients - Kao, Jia-Horng; Jeng, Wen-Juei; Ning, Qin; Su, Tung-Hung; Tseng, Tai-Chung; Ueno, Yoshiyuki; Yuen, Man-Fung (Hepatology international, 2021)
Keywords: Alanine; Alanine transaminase; Antiviral drugs; Biomarkers; Chronic infection; Cirrhosis; Colorectal Surgery; Complications; Deoxyribonucleic acid; DNA; Fibrosis; Guidelines; Hepatitis; Hepatitis B; Hepatitis B e antigen; Hepatitis B surface antigen; Hepatocellular carcinoma; Hepatology; Immune system; Interferon; Liver cancer; Liver cirrhosis; Medicine; Medicine & Public Health; Patients; Risk groups; Strategy; Surgery; Therapy; Viruses; Functional cure; Antiviral therapy; Treatment discontinuation; Relapse; Hepatitis B surface antigen; Monitor; Predictor; Outcome; Finite therapy; Hepatitis B virus